An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

One of the deadliest infectious diseases can be difficult to treat because of drug-resistant strains. But with a new study, scientists from a group of institutions including Scripps Research in La ...

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis TB Alliance has announced a new partnership with the U.S. Fund for UNICEF that will dramatically ...

Yolo County officials traced contacts after a TB case surfaced at Cache Creek Casino. California saw 2,100 TB cases in 2024, with a rising mortality rate of 14%. Health agencies stress screening and ...